OLMA

Olema Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 4/10
  • Momentum↑ 9/10
Olema Pharmaceuticals sales and earnings growth
OLMA Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 19.27%
  • FCF Y/Y↓ -39.27%
Olema Pharmaceuticals gross and profit margin trends
OLMA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -50.60%
Olema Pharmaceuticals net debt vs free cash flow
OLMA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Olema Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗